Home  >  News
Clinical Trials + Font Resize -

Clinical study meant to evaluate effectiveness of anti-VEGF treatment to be released at 11th APVRS congress in Kuala Lumpur

Our Bureau, Mumbai
Thursday, December 7, 2017, 15:50 Hrs  [IST]

The 2-year findings of PLANET, a key clinical study on Polypoidal Choroidal Vasculopathy (PCV) will be released on December 9, 2017 for the first time at the 11th Asia-Pacific Vitreo-retina Society (APVRS) Congress in Kuala Lumpur, Malaysia.

PCV is an age-related eye disease and a common cause of blindness. PLANET evaluates the effectiveness and safety of the anti-VEGF treatment Eylea (Aflibercept) in the treatment of PCV when used as a single therapy.

Prof Wong Tien Yin, medical director, Singapore National Eye Centre and the principal investigator of PLANET will present the study.

A seminar on EYLEA—Extending Horizons in the Management of nAMD and PCV will also be hosted at the APVRS Congress in Kuala Lumpur, Malaysia.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
CPhI-WW-Banners-150X60-120618-anim-v2
pharmalytica_150x60_2018
CPhI_MEA_Banner_150x60_2018
150X60px_biowavers
IPE_2018_Banner_150X60
GPRS_150x60_2018
cphikorea_150x60_saffron media
Chemspec_India-2018
CPhI_China_150x60-2018
PharmaTech_Expo_2018
VF118_Banner_150x60_E_D2
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |